FRED HUTCHINSON CANCER CENTER
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
- Conditions
- Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2011-07-15
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00089037
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2011-11-30
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00089050
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma
- Conditions
- Hepatosplenic T-cell LymphomaIntraocular LymphomaNoncutaneous Extranodal LymphomaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Adult Grade III Lymphomatoid GranulomatosisTesticular LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Immunoblastic Large Cell LymphomaRecurrent Adult T-cell Leukemia/LymphomaRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma
- Interventions
- Drug: chemotherapyRadiation: total-body irradiationProcedure: peripheral blood stem cell transplantationProcedure: allogeneic hematopoietic stem cell transplantationBiological: therapeutic allogeneic lymphocytes
- First Posted Date
- 2004-07-19
- Last Posted Date
- 2019-12-27
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 63
- Registration Number
- NCT00003196
- Locations
- 🇺🇸
City of Hope Medical Center, Duarte, California, United States
🇺🇸Stanford University Hospitals and Clinics, Stanford, California, United States
🇺🇸Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2004-07-19
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00004158
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Sylvester Cancer Center, University of Miami, Miami, Florida, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
- Conditions
- LeukemiaLymphoma
- First Posted Date
- 2004-07-16
- Last Posted Date
- 2011-11-29
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00003874
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
- Conditions
- LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
- First Posted Date
- 2004-06-28
- Last Posted Date
- 2011-11-30
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00005854
- Locations
- 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
🇺🇸University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2004-06-22
- Last Posted Date
- 2011-11-30
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00006241
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer
- Conditions
- Cutaneous B-cell Non-Hodgkin LymphomaJuvenile Myelomonocytic LeukemiaAcute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaChildhood Diffuse Large Cell LymphomaChildhood Nasal Type Extranodal NK/T-cell LymphomaChildhood Grade III Lymphomatoid GranulomatosisMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePeripheral T-cell LymphomaPreviously Treated Myelodysplastic Syndromes
- Interventions
- Radiation: total-body irradiationProcedure: nonmyeloablative allogeneic hematopoietic stem cell transplantationBiological: donor lymphocytesProcedure: peripheral blood stem cell transplantationOther: laboratory biomarker analysis
- First Posted Date
- 2004-06-09
- Last Posted Date
- 2020-01-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT00006251
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
🇮🇹University of Torino, Torino, Italy
Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2011-11-17
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00003195
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00008229
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States